Drug Pipeline
Projected Approvals of Pipeline Gene Therapies Expected to Treat Conditions with Few Options More
Briefing
Insights provides context and perspective about key pharmacy trends and issues
Insights offers context and perspective about key pharmacy and health care topics.
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2019 More
Specialty Report
Drug Pipeline
Biosimilars are a critical tool PBMs can use to help increase market competition and lower costs – we made changes to our template formularies for categories that now have biosimilars... More
Feature
Drug Pipeline
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage the pipeline More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2019 More
Specialty Report
Drug Pipeline
Peanut allergy is the most common of childhood food allergies — and getting more common. Research presented at the annual meeting of the American College of Allergy, Asthma and Immunology (... More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1-Q2 2019 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2018 More
Specialty Report
Drug Pipeline
When the FDA approves a “supplemental indication” for a drug already on the market — permitting it to be used for new conditions or stages of a disease, or additional patient groups – it... More
Briefing
Drug Pipeline
Scientific developments are altering the pace and focus of specialty drug development, while regulatory changes are shortening approval times. This poses new challenges for payors’ efforts... More
Briefing
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2018 More
Specialty Report